Mutations and polymorphisms in genes affecting haemostasis components in children with thromboembolic events

Pathophysiology of Haemostasis and Thrombosis

Volumn 35, Issue 5, 2007, Pages 392-397

  Komitopoulou, A ^a,b   Platokouki, H ^a   Kapsimali, Z ^a   Moschovi, M ^a   Kattamis, A ^a   Pergantou, H ^a   Aronis, S ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Haemostasis; Mutations polymorphisms; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOGEN; PROTEIN C; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; GENE MUTATION; GENETIC POLYMORPHISM; HEMOSTASIS; HETEROZYGOTE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM; THROMBOSIS;

BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION; ODDS RATIO; POLYMORPHISM, GENETIC; THROMBOEMBOLISM;

EID: 33846442823     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097695     Document Type: Article

References (31)

1. Rosendaal FR: Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost 1997;78:1-6.
2. Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, Desai D: Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994;83:1251-1257.
3. Chan AK, Deveber G, Monagle P, Brooker LA, Massicotte PM: Venous thrombosis in children. J Thromb Haemost 2003;1:1443-1455.
4. Kirkham FI: Is there a genetic basis for pediatric stroke? Curr Opin Pediatr 2003;15:547-558.
5. Zoller B, Garcia de Frutos P, Hillarp A, Dahlback B: Thrombophilia as a multigenic disease. Haematologica 1999;84:59-70.
6. Revel-Vilk S, Massicotte P: Thromboembolic diseases of childhood. Blood Rev 2003;17:1-6.
7. Komitopoulou A, Platokouki H, Kapsimali Z, Pergantou H, Adamtziki E, Aronis S: Mutations and polymorphisms in genes affecting hemostasis proteins and homocysteine metabolism in children with arterial ischemic stroke. Cerebrovasc Dis 2006;22:13-20.
8. Lane DA, Grant PJ: Role of hemostatic polymorphisms in venous and arterial thrombotic disease. Blood 2000;95:1517-1532.
9. Alhene-Gelas M, Nicaud V, Gandrille S, van Dresden P, Amiral J, Aubri MI, Emmerich J, Aiach M: The factor V gene A4070G mutation and the risk of venous thrombosis. Thromb Haemost 1999;81:193-197.
10. Ariens RAS, Philippou H, Nagaswami C, Weissel JW, Lane DA, Grant PJ: The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000;96:988-995.
11. Catto AJ, Kohler HP, Bannan S, Stickland M, Carter A, Grant PJ: Factor XIII Val34Leu: a novel association with primary intracerebral haemorrhage. Stroke 1998;29:813-816.
12. Segul R, Estelles A, Mira Y, Espana P, Falco C, Vaya A, Grancha S, Fernando F, Aznar J: PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Br J Haematol 2000;111:122-128.
13. Dellas C, Loskutoff D: Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost 2005;93:631-640.
14. Franco RI, Reitsma PH: Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease. Br J Haematol 2001;115:491-506.
15. Reiner AP, Kumar PN, Schwartz SM, Longstreth WT Jr, Pearce RM, Rosendaal FR, Psaty PM, Siscovick DS: Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 2000;31:1628-1633.
16. Bottiger C, Kastrati A, Koch W, Mehilli J, Seidl H, Schomig K, von Beckerath N, Schomig A: HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost 2000;83:559-562.
17. Reiner AP, Siscovick DS, Rosendaal FR: Hemostatic risk factors and arterial thrombosis disease. Thromb Haemost 2001;85:584-595.
18. Schmidt B, Andrew M: Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995;66:713-717.
19. Nowak-Gottl U, von Kries R, Gobel U: Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997;76:F163-F167.
20. van Ommen H, Heijboer H, Buller H, Hirasing RA, Heijmans H, Peters M: Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands. J Pediatr 2001;139:676-678.
21. Golomb MR, Dick PT, MacGregor DL, Curtis R, Sofronas M, deVeber G: Neonatal ischemic stroke and cerebral sinovenous thrombosis are commonly diagnosed in boys. J Clin Neurol 2004;19:493-497.
22. deVeber G, MacGregor D, Curtis R, Mayank S: Neurologic outcome in survivors of childhood arterial ischemic stroke and cerebral sinovenous thrombosis. J Child Neurol 2000;15:316-324.
23. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993;342:1503-1506.
24. Faioni EM, Franchi F, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, Finazzi G, Mannucci PM: Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism in carriers of factor V R506Q (Factor V Leiden). Blood 1999;94:3062-3066.
25. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
26. Nowak-Gottl U, Kosch A, Schlegel N, Salem M, Manco-Johnson M: Thromboembolism in children. Curr Opin Hematol 2002;9:448-453.
27. Young G, Manco-Johnson M, Gill JC, Dimichele DM, Tarantino MD, Abshire T, Nugent DJ: Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study. J Thromb Haemost 2003;1:958-962.
28. Humphries SE, Henry JA, Montgomery HE: Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis. Blood Coagul Fibrinolysis 1999;10:S17-S21.
29. Dellas C, Loskutoff DJ: Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost 2005;93:631-640.
30. Iacoviello L, Burzotta F, Di Casteinuovo A, Zito F, Marchioli R, Donati MB: The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis. Thromb Haemost 1998;80:1029-1030.
31. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker IC, Weiss JL, Gersternblith G, Goldschmidt-Clermont PJ: A polymorphism of platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996;334:1090-1094.